|
Rimiducid Clinical Trials
4 actively recruiting trials across 4 locations
Pipeline
Phase 1: 4
Top Sponsors
- Poseida Therapeutics, Inc.2
- M.D. Anderson Cancer Center1
- Genentech, Inc.1
Indications
- Cancer3
- Systemic Lupus Erythematosus1
- DLBCL NOS1
- DLBCL, Diffused Large B Cell Lymphoma1
- DLBCL Arising From Follicular Lymphoma1
Birmingham, Alabama1 trial
A Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Pharmacodynamics, and Efficacy of P-CD19CD20-ALLO1 in Participants With Severe, Treatment-refractory Systemic Lupus Erythematosus (SLE)
University of Alabama at Birmingham: The Kirklin Clinic
Phase 1
Goodyear, Arizona1 trial
La Jolla, California1 trial
P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies
University of California San Diego
Phase 1
Houston, Texas1 trial
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.